Transport of opioid peptides into the central nervous system

Journal of Pharmaceutical Sciences

Volumn 87, Issue 11, 1998, Pages 1433-1439

  Egleton, Richard D ^a   Abbruscato, Thomas J ^a   Thomas, Sarah A ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIPHALIN; ENKEPHALIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; METENKEPHALIN; MORPHINE; NEUROTRANSMITTER; OPIATE PEPTIDE; OPIATE RECEPTOR; PEPTIDE HORMONE;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; CATTLE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIFFUSION; DRUG TRANSPORT; ENDOTHELIUM CELL; FEMALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031763418     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980062b     Document Type: Conference Paper

References (47)

1. Butt, A. M.; Jones, H. C.; Abbott, N. J. Electrical resistance across the blood-brain barrier in anaesthetized rats. J. Physiol (London). 1990, 429, 47-62.
2. Crone, C.; Cristensen, O. Electrical resistance of capillary endothelium. J. Gen. Physiol. 1981, 77, 349-371.
3. Brightman, M. Ultrastructure of brain endothelium. In: Handbook of experimental pharmacology 103. Physiology and pharmacology of the blood-brain barrier. Bradbury, M. W. B., Ed.; Springer-Verlag, Berlin, 1992; pp 1-22.
4. Brownlees, J.; Williams, C. H. Peptidases, peptides at the mammalian blood-brain barrier. J. Neurochem. 1993, 60, 793-803.
5. Brownson, E. A.; Abbruscato, T. J.; Gillespie, T, J.; Hruby, V. J.; Davis, T. P. Effect of peptidases at the blood-brain barrier on the permeability of enkephalin. J. Pharm. Exp. Ther. 1994, 270, 675-680.
6. Egleton, R. D.; Davis, T. P. Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 1997, 18, 1431-1439.
7. Terasaki, T.; Ichihirai, K; Sato, H.; Rang, Y. S.; Tsuji, A. Adsorptive mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier. J. Pharm. Exp. Ther. 1989, 257, 351-357.
8. Takada, Y.; Grieg, N. H.; Vistica, D. T.; Rappoport, S. I.; Smith, Q. R. Affinity of antineoplastic drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother. Pharmacol. 1991, 29, 89-94.
9. Chikhale, E. G.; Chikhale, P. J.; Borchardt, R. T. Carrier mediated transport of the antitumor agent acivicin across the blood-brain barrier. Biochem. Pharmacol. 1995,49, 941945.
10. Krämer, T. H.; Shook, J. E.; Kazmierski, W.; Ayers, E. A.; Wire, W. S.; Hruby, V. J.; Burks, T. F. Novel peptidic mu opioid antagonists: pharmacological characterization in vitro and in vivo. J. Pharm. Exp. Ther. 1989, 249, 544-549.
11. Wang, Z.; Bilsky, E. J.; Porecca, F.; Sadee, W. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sei. 1994, 54, PL339-PL350.
12. Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Gee, K.; Yamamura, H. I.; Galligan, J. J.; Burks, T. F. Bis-penicillamine enkephalins possess highly improved specificity toward o-opioid receptors. Proc. Natl. Acad. Sei., U.S.A. 1983,80, 5871-5874.
13. Weber, S. J.; Greene, D. L.; Sharma, S. D.; Yamamura, H. L; Kramer, T. H.; Burks, T. F.; Hruby, V. J.; Hersh, L. B.; Davis, T. P. Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogues after intravenous administration. J. Pharm. Exp. Ther. 1991,259,1109-1117.
14. Weber, S. J.; Greene, D. L.; Hruby, V. J.; Yamamura, H. I.; Porreca; Davis T. P. Whole body and brain distribution of [SHjcyclic [D-Pen2, D-Pen5]enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration. J. Pharm. Exp. Ther. 1992, 263, 1308-1316.
15. Horan, P. J.; Mattia, A.; Bilsky, E. J.; Weber, S.; Davis, T. P.; Yamamura, H. L; Malatynska, E,.; Appleyard, S. M.; Slaninova, J.; Misicka, A.; Lipkowski, A. J.; Hruby, V. J.; Porreca, F. Antinociceptive profile of biphalin, a dimeric enkephalin analog. J. Pharm. Exp. Ther. 1993, 265, 14461454.
16. Audus, K. L.; Borchardt, R. T. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 1986, 3, 81-87.
17. Preston, J. E.; Al-Sarraf, H.; Segal, M. B. Permeability of the developing rat blood-brain barrier to 14C mannitol using the rat in situ brain perfusion technique. Dev. Brain Res. 1995, 87, 69-76.
18. Gjedde, A. High- and low-affinity transport of D-glucose from blood to brain. J. Neurochem. 1981, 36, 1463-1471.
19. Patlak, C. S.; Fenstermacher, J. D.; Blasberg, R. G. Graphical evaluation of blood-to-brain transfer constants from multipletime uptake data. J. Cereb. Blood Flow. Metab. 1983,3, 1-7.
20. Triguero, D.; Buciak, J. B.; Yang, J.; Pardridge, W. M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 1990, 54, 1882-1888.
21. Erchegyi, J.; Kastin, A. J.; Zadina, J. E.; Qiu, X.-D. Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-The-Gln(valorphin) with some opiate activity. Int. J. Peptide Protein Res. 1991, 39, 477-488.
22. Zlokovic, B. V.; Begley, D. J.; Djuricic, B. M.; Mitrovic, D. M. Measurement of solute transport across the blood-brain barrier in the perfused guinea-pig brain: method and application to A?-methyl- -aminoisobutyric acid. J. Neurochem. 1986, 46, 1444-1451.
23. Gjedde, A. Exchange diffusion of large neutral amino acids between blood and brain. In Peptide and amino acids transport mechanisms in the central nervous system. Rakic, L., Begley, D. J., Davson, H., Zlokovic, B. V., Eds.; Macmillan: London, 1988; pp 209-217.
24. Zlokovic, B. V.; Mackic, J. B.; Djuricic, B. M.; Davson, H. Kinetic analysis of leucine enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 1989, 53, 1333-1340.
25. Gjedde, A. Modulation of substrate transport to the brain Acta Neural. Scand. 1983, 67, 3-25.
26. Smith, Q. R.; Takasato, Y.; Rapoport, S. I. Kinetic analysis of L-leucine transport across the blood-brain barrier. Brain Res. 1984, 311, 167-170.
27. Takasato, Y.; Momma, S.; Smith, Q. R. Kinetic analysis of cerebrovascular isoleucine transport from saline and plasma. J. Neurochem. 1985, 45, 1013-1020.
28. Abbruscato, T. J.; Williams, S. A.; Misicka, A.; Lipkowski, A. W.; Hruby, V. J.; Davis, T. P. Blood-to-central nervous system entry and stability of biphalin, a unique doubleenkephalin analogue, and its halogenated derivatives. J. Pharm. Exp. Ther. 1996, 276, 1049-1057.
29. Abbruscato, T. J.; Thomas, S. A.; Hruby, V. J.; Davis, T. P. Blood-brain barrier permeability and bioavailability of a highly potent and /(-selective opioid receptor antagonist, CTAP: comparison with morphine. J. Pharm. Exp. Ther. 1997, 280, 402-409.
30. Abbruscato, T. J.; Thomas, S. A.; Hruby, V. J.; Davis, T. P. Brain and spinal cord distribution of biphalin: Correlation with opioid receptor density and mechanism of CNS entry. J. Neurochem. 1997, 69, 1236-1245.
31. Williams, S. A.; Abbruscato, T. J.; Hruby, V. J.; Davis, T. P. Passageofa<3-opioidreceptorselectiveenkephalm[D-p8mciIlarnine2''Jenkephalin, across the blood-brain and blood-cerebrospinal fluid barriers. J. Neurochem. 1996, 66, 1289-1299.
32. Thomas, S. A.; Abbruscato, T. J.; Hruby, V. J.; Davis, T. P. The entry of [D-pemcillamine2'5]enkephalin into the central nervous system: saturation kinetics and specificity. J. Pharm. Exp. Ther. 1997,280, 1235-1240.
33. Miller, D. W.; Keller, B. T.; Borchardt, R. T. Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: possible function in insulin processing in the blood-brain barrier. J. Cell Physiol. 1994, 161, 333-341.
34. Raub, T. J.; Audus, K. L. Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers. J. Cell Sei. 1990, 97, 127-138.
35. Guillot, F. L.; Audus, K. L.; Raub, T. Fluid-phase endocytosis by primary cultures of bovine brain microvessel endothelial cell monolayers. Microvascular Res. 1990, 39, 1-14.
36. Weber, S. J.; Abbruscato, T. J.; Brownson, E. A.; Lipkowski, A. W.; Polt, R. Misicka, A.; Haaseth, R.; Bartosz, H.; Hruby, V. J.; Davis, T. P. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogues. J. Pharm. Exp. Ther. 1993, 266, 1649-1655.
37. Thomas, S. A.; Abbruscato, T. J.; Hau, V. S.; Gillespie T. J.; Zsigo, J.; Hruby, V. J.; Davis, T. P. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain permeability and stability. J. Pharm. Exp. Ther. 1997, 281, 817-825.
38. Pardridge, W. M.; Triguero, D.; Yang, J. P. A. Comparisons of in vitro and in vivo models of transcytosis through the blood-brain barrier. J. Pharm. Exp. Ther. 1990, 253, 884891.
39. Banks, W. A.; Schally, A. V.; Barrera, C. M.; Fasold, M. B.; Durham, D. A.; Csernus, V. J.; Groot, K.; Kastin, A. J. Permeability of the murine blood-brain barrier to some octapeptide analogues of somatostatin. Proc. Natl. Acad. Sei., U.S.A. 1990, 87, 6762-6766.
40. Gaudriault, G.; Nouel, D.; Dalfarra, C.; Beaudet, A.; Vincent, J. P. Receptor-induced internalization of selective peptidic mu and (5-opioid ligands. J. EM. Chem. 1997, 272, 28802888.
41. Ayre, S. G.; Skaletski, B.; Mosnaim, A. D. Blood-brain barrier passage of azidodeoxythymidine in rats: effect of insulin. Res. Commun. Chem. Pathol. Pharmacol. 1989, 63, 45-52.
42. Alabaster, O.; Vonderhaar, B. K.; Shafie, S. M. Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 breast cancer cells. Eur. J. Cancer Clin. Oncol. 1981, 17, 1223-1228.
43. Davson, H.; Segal, M. B. Physiology of the CSF and bloodbrain barriers. CRC: London, 1995.
44. Prokai-Tatrai, K; Prokai, L.; Bodor, N. Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design. J. Med. Chem. 1996, 39, 9, 4775-4782.
45. Ganwar, S.; Pauletti, G. M, Siahaan, T. J.; Stella, V. J.; Borchardt, R. T. Synthesis of a novel esterase-sensitive cyclic prodrug of a hexapeptide using an (acloxy)alkoxy promoiety. J. Org. Chem. 1997, 62, 2, 1356-1362.
46. Polt, R.; Porreca, F.; Szabo, L. Z.; Bilsky, E. J.; Davis, P.; Abbruscato, T. J.; Davis, T. P.; Horvath, R.; Yamamura, H, I.; Hruby, V. J. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc. Natl. Acad. Sei., U.S.A. 1994, 91, 7114-7118.
47. Williams, S. A.; Abbruscato, T. J.; Szabo, L.; Polt, R.; Hruby, V.; Davis, T. P. The effect of glycosylation on the uptake of an enkephalin analogue into the central nervous system. In Biology and physiology of the blood-brain barrier. Couraud, J. P., Scherman, D., Eds.; Plenum: New York, 1996; pp 69-77.